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Membrane proteinase 3 expression and ANCA-induced
neutrophil activation
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Membrane proteinase 3 expression and ANCA-induced neu-
trophil activation.
Background. Proteinase 3 is the major autoantigen in
Wegener’s granulomatosis (WG). Membrane PR3 expression
is bimodal; low expressing cells (mPR3low) can be distinguished
from cells with high expression (mPR3high) within a given indi-
vidual. High mPR3 expression is a WG risk factor and is associ-
ated with relapse. However, no mechanisms for this important
clinical observation have been provided. We tested the hypoth-
esis that mPR3 expression, rather than the expression of other
membrane molecules implicated in anti-neutrophil cytoplasmic
autoantibodies (ANCA) activation, determines the robustness
of the PR3-ANCA-mediated response.
Methods. mPR3low and mPR3high neutrophils from a given
individual were separated by magnetic cell sorting. Superoxide
was measured by the ferricytochrome assay, and Akt phospho-
rylation by Western blotting. Double staining and flow cytome-
try were used to assay Fcc-receptor and b2-integrin expression
with respect to the mPR3 phenotype. Degranulation was
measured via b-glucuronidase activity, migration with
fibronectin-coated transwells, and cell quantification by the
myeloperoxidase (MPO) assay.
Results. PR3-ANCA-treated mPR3high versus mPR3low neu-
trophils showed more superoxide generation (33.7 ± 15.2 nmol
O2− to 14.6 ± 8.4, P < 0.01), more degranulation (29% ± 5 to
22% ± 3, P < 0.05), and more PI3-K/Akt activation. In contrast,
all responses in both mPR3 subsets were similar after other stim-
uli. We observed no differences in the b2-integrin, FccR IIa, and
III expression with respect to the mPR3 subtype. Furthermore,
we found no differences in the mobilization of PR3-containing
granules and no differences in migration through fibronectin.
Conclusion. The degree of neutrophil mPR3 expression has
definitive functional consequences.
Wegener’s granulomatosis (WG) is characterized by
anti-neutrophil cytoplasmic autoantibodies (ANCA) [1]
with specificity for proteinase 3 (PR3) [2]. A pathogenic
role for ANCA is suggested by several in vitro stud-
ies. The emerging picture is that ANCA interact with
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their target antigens on cytokine-primed neutrophils and
on monocytes activating intracellular signal transduc-
tion pathways, such as PI3-K/Akt [3–6]. ANCA-activated
neutrophils and monocytes generate reactive oxygen
species (ROS), release toxic granule components, and up-
regulate surface adhesion molecules, ultimately causing
vascular damage [7–12]. Recently, the pathogenic role of
ANCA was elegantly demonstrated in an animal model
[13]. The major target antigen in WG is PR3. This serine
protease is localized in azurophilic (primary) and specific
(secondary) granules, and in secretory vesicles [14–16]. In
addition to an intracellular pool, PR3 can be detected on
the surface of isolated resting neutrophils [16, 17]. Mem-
brane PR3 (mPR3) expression is bimodal. Within a given
donor an mPR3high and mPR3low subset neutrophil pop-
ulation can be distinguished [18, 19]. We found recently
that the mPR3 phenotype is under strong genetic influ-
ences [20]. A large percentage of mPR3high neutrophils
provides a risk factor for vasculitis and is associated with
relapse [19–21]. Possibly, neutrophils with high mPR3 ex-
pression can more easily interact with PR3-ANCA, re-
sulting in stronger activation. We investigated whether or
not the mPR3 phenotype affects ANCA-induced respira-
tory burst, intracellular signaling, and release of granule
proteins. Because additional surface molecules, includ-
ing b2-integrins and Fcc receptors IIa and IIIb, were
reported to be important for neutrophil activation by
ANCA, we also studied the expression of these molecules
in the mPR3high and mPR3low neutrophil subsets. Finally,
mPR3 is enzymatically active and is resistant to the nat-
urally occurring inhibitors alpha1-antitrypsin and elafin
[22]. Because PR3 degrades extracellular matrix com-
ponents such as fibronectin [22–24], we examined the
possibility that high mPR3 expression favors chemotactic
migration.
METHODS
Materials
Recombinant tumor necrosis factor (TNF)-a was
obtained from Genzyme (Ru¨sselsheim, FRG). The
2172
Schreiber et al: ANCA-induced neutrophil activation 2173
monoclonal mouse antibody to PR3 was obtained from
CLB (Amsterdam, The Netherlands), and fluoroscein
isothiocyanate (FITC)-conjugated F(ab)2-fragment of
goat antimouse immunoglobulin (Ig)G was from Dako
(Hamburg, FRG). Dextran was purchased from Amer-
sham Pharmacia (Amsterdam, The Netherlands). Hank’s
balanced salt solution (HBSS), phosphate-buffered
saline (PBS), and Trypan blue were from Seromed
(Berlin, FRG). Endotoxin-free reagents and plastic dis-
posables were used in all experiments. Histopaque 1083
was obtained from Sigma-Aldrich (Deisenhofen, FRG).
The following antibodies were used: from Immunotech
(Krefeld, FRG), CD11a (FITC), CD11b (FITC), CD11c
(PE), and CD18 (FITC). CD16 and CD35 (FITC) were
from Cymbus Biotech (Hants, UK), and CD32 (FITC)
from Dako. CD63 (PE) was from CLB.
Isolation of human neutrophils
Neutrophils from healthy volunteers were isolated
from heparinized whole blood by red blood cell sedi-
mentation with dextran 1%, followed by Ficoll-Hypaque
density gradient centrifugation, and hypotonic erythro-
cyte lysis. Neutrophils were centrifuged (10 minutes at
1050 rpm) and resuspended in HBSS with calcium and
magnesium (HBSS++). The cell viability was detected in
every cell preparation by Trypan blue exclusion and ex-
ceeded 99%. The neutrophil percentage in the suspension
was >95% by Wright-Giemsa staining.
Preparation of immunoglobulins
Human immunoglobulin G (IgG) was prepared from
patients with biopsy-proven WG (two PR3-ANCA) and
microscopic polyangiitis (two MPO-ANCA) as well as
from two healthy control subjects as described [25].
Separation of mPR3high and mPR3low neutrophils
by magnetic beads
mPR3high and mPR3low neutrophils were separated
with magnetic cell sorting (MACS) separation columns
(Miltenyi Biotec, Bergisch Gladbach, Germany) as de-
scribed in the manufacturer’s manual. All steps were
carried out on ice. Freshly isolated neutrophils were
stained with a monoclonal antibody (mab) to PR3 (CLB
12.8,IgG1j). MACS rat antimouse IgG1 were added,
and cells were pipetted onto a MACS LD Column (Mil-
tenyi Biotech). The flow-through containing the nonla-
beled mPR3low neutrophils was collected. Columns were
removed from the magnet and labeled mPR3high neu-
trophils were collected. The cell 99% viability was de-
tected in every cell preparation by Trypan blue exclusion.
Assessment of neutrophil adhesion
Well plates (96-well) coated with (10 lg/cm2) fi-
bronectin were used for the adhesion assay. Polymor-
phonuclear cells (PMN) (1 × 105) in 100 lL HBSS++
were either left untreated or were treated with 2 ng/mL
TNF-a. Plates were incubated at 37◦C in 5% CO2 for
the indicated time period. Wells were flicked dry, washed
three times with PBS, and adherent cells were estimated
using the MPO assay. Briefly, adherent cells were lysed
in 100 lL of 0.5% Triton-X-100 for 10 minutes. Sub-
strate (100 lL; 2.2’-Azino-bis (3-Ethylbenzthiazoline-6-
sulfonicacid; Sigma, Deisenhofen, FRG) was added and
optical density (OD) was read after 10 minutes at 450 nm
with a microtiter plate reader. OD of the experimental
sample was compared with a standard curve that showed
an excellent correlation between OD and cell number
(R2 = 0.96).
Superoxide generation assay
Superoxide was measured using the assay of SOD-
inhibitable reduction of ferricytochrome C as described
by Pick and Mizel [26]. Neutrophils were pretreated with
5 lg/mL cytochalasin B for 15 minutes. Cells (0.75 × 106)
were primed with 2 ng/mL TNF-a for 15 minutes before
human ANCA preparations were added. No priming was
performed for phorbol 12-myristate 13-acetate (PMA) or
N-formyl-methionyl-leucyl-phenyalanine (fMLP) stimu-
lation. The final concentrations were 125 lg/mL for pu-
rified IgG preparations, 25 ng/mL for PMA, and 10−6
mol/L for fMLP. Experiments were done in duplicate.
Samples were incubated in 96-well plates at 37◦C for
up to 60 minutes, and the absorption of samples with
and without 300 U/mL SOD was scanned repetitively at
550 nm using a Microplate Autoreader (Molecular De-
vices, Munich, Germany). The final ferricytochrome C
concentration was 50 lmol/L, and the final cell concen-
tration was 3.75 × 106/mL.
Degranulation assay
Freshly isolated neutrophils (5 × 105) were preincu-
bated with 5 lg/mL cytochalasin B and primed in a 96-
well microtiter plate for 15 minutes with 2ng/mL TNF-a.
Stimulation was performed with PR3-ANCA or MPO-
ANCA or human control IgG or fMLP 10−6 mol/L for
up to 120 minutes. At 30-minute intervals the cell-free su-
pernatants were collected by centrifugation (7 min, 250g),
and b-glucuronidase activity was assessed by the cleav-
age of phenolphtaleinglucuronic acid (Sigma-Aldrich).
Each tube contained 50 lL of a 0.01 mol/L solution
phenolphtalein-glucuronic acid in 0.1 mol/L acetic buffer,
pH 4.6, with 0.04% Triton X-100, and was mixed with
50 lL of the cell-free supernatant. After a 14-hour incu-
bation in the dark at 37◦C, the reaction was stopped by
adding 1 mL of a 0.02 mol/L solution of glycine buffer,
pH 10.4. OD values were measured at 405 nm. Nonstim-
ulated neutrophils served as baseline, whereas the total
neutrophil b-glucuronidase content was obtained by in-
cubation 5 × 105 neutrophils with 1% Triton X-100.
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Determination of surface antigen expression
by flow cytometry
Fluorescence-activated cell sorting (FACS) was used
as described previously to evaluate the PR3 expres-
sion on neutrophils [25]. For double labeling, cells were
incubated after stimulation with conjugated antibodies
against CD11a, CD11b, CD11c, CD16, CD32, CD35, and
CD63. Flow cytometry was performed using a FACSort
(Becton Dickinson, Heidelberg, FRG), and 10,000 events
per sample were collected.
Transmigration assay
The ability of neutrophils to migrate through extra-
cellular matrix components was tested with 20 lg/mL
fibronectin-coated transwells (3.0 lm, 6.5 mm from
Corning, NY, USA). Neutrophils (1.5 × 106) in HBSS++
were stimulated at 37◦C with 50 ng/mL interleukin-8 to
transmigrate to the lower well. For time-course studies,
the upper chamber of the transwell device was gently
moved to a new well in 30-minute intervals. Transmi-
grated cells were quantified by MPO assay as described
previously [27], and are given as the percentage of neu-
trophils that migrated from the apical to the basal aspect
of the insert membranes. Calculation was done as fol-
lows: percentage migration = (MPO − activity of basal
fluid/MPO activity of the neutrophil suspension added
to apical aspect) × 100. When indicated, transmigrated
neutrophils were stained for surface PR3 and analyzed
by FACS.
Western blot analysis for phosphorylated Akt and ERK
Neutrophils were incubated after separation of
mPR3high and mPR3low at a concentration of 2 × 106/mL
in the presence of buffer control or with the indicated
stimuli. Western blotting was performed as previously
described using phosphospecific antibodies [5]. Densit-
ometry was performed with scanned x-ray films and the
NIH image program.
Statistical analysis
Results are given as mean ± SEM. Comparisons were
made by t test or analysis of variance (ANOVA) as ap-
propriate.
RESULTS
ANCA-induced superoxide generation in mPR3high
and mPR3low neutrophils
We tested the hypothesis that low and high mPR3 neu-
trophils differ in the magnitude of PR3-ANCA-induced
activation. To exclude interaction between both subsets,
we physically separated mPR3high and mPR3low neu-
trophils by magnetic cell sorting. We yielded two pop-
ulations of cells with >90% of mPR3high and >90%
mPR3low, respectively (Fig. 1A-C). After sorting, neu-
trophils were primed with TNF-a and subsequently
activated with PR3-ANCA, MPO-ANCA, control im-
munoglobulins, respectively, or unprimed cells were stim-
ulated with PMA. Stimulation of mPR3high neutrophils
(Fig. 2) resulted in significantly higher amounts of su-
peroxide generation, compared to mPR3low cells (33.7 ±
15.2 nmol O2−/105 neutrophils vs. 14.6 ± 8.4, P < 0.001,
N = 5). In contrast, no difference in the response to hu-
man control immunoglobulins, MPO-ANCA, or PMA
was observed. We performed experiments to ensure that
the sorting algorithm did not influence neutrophil respon-
siveness, and that the separated mPR3low and mPR3high
subgroups were not characterized by different activation
status. We preincubated neutrophils with buffer control,
mab to PR3, and mab to PR3 together with beads, respec-
tively. After this preincubation samples were either chal-
lenged with TNF-a/human PR3-ANCA or with buffer
control for 45 minutes. Superoxide generation was sim-
ilar in the three preincubation groups after stimulation
with TNF-a/human PR3-ANCA. The results were 16.5 ±
0.7 nmol/0.75 × 106 cells/45 minutes in the buffer prein-
cubation group versus 14.0 ± 0.2 nmol in samples prein-
cubated with mab to PR3 alone, and 14.5 ± 2.2 nmol
in samples with the mab to PR3 together with beads.
In contrast, buffer control did not result in superoxide
generation in any of the three preincubation groups. The
results were 2.9 ± 1.4 nmol/0.75 × 106 cells/45 minutes
in the buffer preincubation group versus 1.5 ± 2.2 nmol
in samples preincubated with mab to PR3 alone, and
2.5 ± 2.1 nmol in samples with the mab to PR3 together
with beads. In addition, our results from Western blot
experiments indicate that the sorting procedure did not
affect basal or TNF-a-induced phosphorylation of extra-
cellular signal-regulated kinase (ERK) (Fig. 1D). ERK
is a sensitive indicator of neutrophil activation. We have
shown previously that ERK controls neutrophil priming
[25]. Together, these experiments exclude the possibility
that the sorting technique used in this study affected neu-
trophil responsiveness. These data also provide evidence
that mPR3high neutrophils do not represent a more acti-
vated subgroup of cells. When we assessed the percent-
age of mPR3high cells in isolated neutrophils aged over
24 hours in culture, we observed no change in this per-
centage in two independent experiments (0 h: 64% ± 16.9
mPR3high neutrophils; 2 h: 65% ± 16.3; 4 h: 65% ± 16.3;
8 h: 65% ± 16.9; 12 h: 66% ± 16.3; 24 h: 67% ± 18.4).
These experiments exclude both age and activation sta-
tus as important factors affecting the percentage of
mPR3 expression. Next, we titrated a dose response
curve using neutrophils from a given individual. We
chose this approach because interindividual compar-
isons are of limited help in neutrophil investigations be-
cause of the large degree of variation between different
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Fig. 1. Membrane proteinase 3 (mPR3) staining of neutrophils sepa-
rated by magnetic cell sorting was assessed by flow cytometry (A-C)
and extracellular signal-regulated kinase (ERK) phosphorylation by
immunoblotting (D). The isotype control staining is depicted in each
panel as a dotted line. Before magnetic cell sorting, 56% of the neu-
trophil population expressed PR3 on their plasma membrane (A). Sort-
ing yielded two populations containing either 94% mPR3low cells (B)
or 95% mPR3high cells (C). After the sorting procedure, mPR3low and
mPR3high cells were treated with either buffer (CTRL) or 2 ng/mL TNF-
a (TNF) for 10 minutes, and ERK activation was estimated by Western
blot experiments. The data indicate that ERK was not phosphorylated
by cell sorting, per se, and that TNF-a priming resulted in a similar phos-
phorylation increase. Reprobing for actin demonstrates equal protein
loading. A typical of two independent experiments is shown.
CTRL TNF TNF CTRL
ERKP
PR3low PR3high
Actin
D
Fig. 1. Continued.
donors. Neutrophils were isolated, and the mPR3high and
mPR3low subset were separated and remixed to achieve
defined samples containing less than 10%, approximately
25%, 50%, 75%, and >90% mPR3high cells. Samples
were primed with TNF-a, stimulated with PR3-ANCA,
and superoxide generation was assayed. We observed
a superoxide response that increased dose dependently
with increasing the percentage of mPR3high-neutrophils
(Fig. 3). A progressive increase in burst activity occurred
from <10% up to 75% mPR3high-cells and a plateau
thereafter.
Phosphylation of Akt in mPR3high and
mPR3low neutrophils
We studied whether or not the differences in superox-
ide generation after PR3-ANCA stimulation of mPR3high
and mPR3low neutrophils were related to differences in
PI3-K/Akt activation. After separation of both mPR3
subsets, samples were primed with TNF-a for 15 minutes
and stimulated with PR3-ANCA, MPO-ANCA, or hu-
man control immunoglobulins for another 15 minutes. We
had previously observed that TNF-a–induced Akt phos-
phorylation peaked after 10 minutes, declining thereafter,
and that ANCA resulted in a second phosphorylation
peak [5]. The simulation with control immunoglobulins
induced very little Akt phosphorylation (Fig. 4), whereas
PR3-ANCA and MPO-ANCA resulted in a significant
activation of Akt. However, Akt phosphorylation was
significantly higher in PR3-ANCA–stimulated mPR3high
neutrophils compared with the mPR3low subset. In
contrast, no difference was observed after stimulation
with MPO-ANCA. Corresponding optical density (OD)
measures are given in Figure 4B.
Degranulation in mPR3high and mPR3low neutrophils
ANCA were shown to stimulate neutrophil degranu-
lation. Thus, we explored whether or not PR3-ANCA–
induced release of granule proteins was higher in the
mPR3high subset compared to the PR3low cells. After
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ils Fig. 2. Superoxide generation with respect
to mPR3 expression. mPR3high and mPR3low
neutrophils from 4 different healthy donors
were separated by magnetic cell sorting. TNF-
a–primed cells were stimulated with 125
lg/mL immunoglobulin (Ig)G from two dif-
ferent healthy controls (control), two dif-
ferent PR3-ANCA patients, two different
MPO-ANCA patients, or 50 ng/mL PMA, re-
spectively (N = 4). Superoxide production
was measured with the continuous ferricy-
tochrome assay, and the 45-minute time point
is depicted. mPR3high neutrophils are shown
as white bars, mPR3low cells as black bars.
The results demonstrate significantly more su-
peroxide generation in mPR3high neutrophils
only after treatment with PR3-ANCA, but not
with the other stimuli. ∗∗P < 0.001.
separation of both populations, TNF-a–primed samples
were challenged with human PR3-ANCA, MPO-ANCA,
and human control immunoglobulins, respectively. Be-
cause PMA did not trigger degranulation (data not
shown), we used fMLP as an additional stimulus in this
assay (Fig. 5). We found significant higher degranulation
after stimulation with PR3-ANCA (29% ± 5 of total cel-
lular b-glucuronidase vs. 22% ± 3, P < 0.05, N = 4).
In contrast, no difference was observed after stimulation
with human control immunoglobulins, MPO-ANCA, or
fMLP.
b2-integrin, FccRIIa, and FccRIIIb expression
on mPR3high and mPR3low neutrophils
We investigated the expression of b2-integrins,
FccRIIa, and FccRIIIb because these receptors were
implicated in ANCA-induced neutrophil activation. We
used double staining and flow cytometry to assess these
molecules in both mPR3high and mPR3low subsets. The
experiments were performed in unstimulated cells, in
TNF-a–primed cells, in TNF-a–primed cells challenged
with a mab to MPO or to PR3, or with fMLP, re-
spectively. First, the b2-integrins were analyzed. We
observed no difference in CD11a (LFA-1), CD11b
(Mac-1; CR3), CD11c (p150,95; CR4), or CD18 ex-
pressions in resting mPR3high and mPR3high neutrophils
(Fig. 6). We confirmed the increase in the amount of
membrane-expressed CD11b, CD11c, and CD18 after
incubating with the aforementioned activators, whereas
CD11a was not up-regulated upon stimulation. How-
ever, we found that the up-regulation of these inte-
grin molecules was similar in PR3high and PR3low cells
(Table 1).
In addition to studying the expression of adhesion
molecules, we assessed the ability of mPR3low and
mPR3high neutrophils to adhere to extracellular ma-
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Fig. 3. Dose-response curve for the effect of mPR3 expression on su-
peroxide production of PR3-ANCA–treated neutrophils. Neutrophils
from a given donor were separated into mPR3high and mPR3low cells by
magnetic sorting and remixed after separation to achieve samples with
exactly defined percentages of mPR3high neutrophils as indicated. After
TNF-a priming, cells were incubated with 125 lg/mL PR3-ANCA (N =
2 with 2 different PR3-ANCA preparations). Superoxide was measured
with the ferricytochrome assay, and data from the 45-minute time point
are depicted. These experiments demonstrate that the PR3-ANCA–
induced respiratory burst increased dose dependently with increasing
the percentage of mPR3high neutrophils.
trix proteins. mPR3low and mPR3high neutrophils were
separated by magnetic cell sorting and incubated on a
fibronectin-coated surface in the absence and presence
of 2 ng/mL TNF-a. Cells were harvested after 60 min-
utes, and adhesion was determined using the MPO-assay.
We observed similar adhesion of mPR3low and mPR3high
neutrophils after incubation in buffer control (3.4 ± 0.9 ×
104 and 4.0 ± 1.3 × 104 neutrophils, respectively). Fur-
thermore, both populations showed a similar increase in
adherence after stimulation with TNF-a (7.0 ± 0.5 × 104
and 7.9 ± 1.3 × 104, respectively, N = 2).
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B Fig. 4. Phosphorylation of Akt in response
to ANCA-stimulation in mPR3high and
mPR3low neutrophils was studied by im-
munoblotting. (A) mPR3high and mPR3low
neutrophils were separated in 4 indepen-
dent experiments from 4 different healthy
donors by magnetic cell sorting. Cells were
left untreated (cells) or primed for 15 minutes
with 2 ng/mL TNF-a. Samples were subse-
quently incubated for another 15 minutes with
buffer (cells and TNF), PR3-ANCA (from
two different patients, PR3-ANCA), MPO-
ANCA (from two different patients, MPO-
ANCA) or human control immunoglobulins
(from two different donors, Ctr). To show
equal protein loading the blot was stripped
and reprobed for actin. (B) The densitometric
analysis demonstrated that PR3-ANCA treat-
ment of mPR3high neutrophils resulted in sig-
nificant more Akt phosphorylation (mPR3high
are shown as white bars, mPR3low as black
bars, ∗P < 0.05).
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Fig. 5. Degranulation of mPR3high and
mPR3low neutrophils. Neutrophils from 5
different healthy donors were separated
by magnetic cell sorting. TNF-a–primed
cells were incubated with two different
preparations of control immunoglobulins,
PR3-ANCA, MPO-ANCA, or fMLP (10−6
mol/L). Degranulation was measured by
b-glucuronidase-release, and the results at 45
minutes are depicted (mPR3high are shown as
white bars, and mPR3low as black bars). The
data demonstrate significant differences for
the stimulation with PR3-ANCA. ∗∗P < 0.01.
We then investigated the expression pattern of the Fcc-
receptor IIA (CD32) and FccIIIb (CD16), which were
also reported to play a role in neutrophil activation by
ANCA. The expression of both receptors was similar
in mPR3high and mPR3low resting neutrophils (Fig. 7).
Again, this finding did not change when cells were stim-
ulated (Table 1). Because of the necessary fluorescence
compensation for double-staining experiments compar-
isons between the stimuli are difficult. Our aim is merely
a comparison between both mPR3high and mPR3low neu-
trophils for a given activator. Taken together, our exper-
iments did not detect additional differentially expressed
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Fig. 6. The expression of 2 integrins in
mPR3high and mPR3low neutrophils was com-
pared by double staining and flow cytome-
try. Unstimulated isolated neutrophils were
stained with both anti-PR3 and anti-b2-
integrin mab. The data demonstrate no differ-
ence in the expression of CD11a (A), CD11b
(B), CD11c (C), or CD18 (D) with respect to
mPR3 expression.
Table 1. Increased expression of different surface markers in mPR3high and mPR3low neutrophils was studied by double staining and flow
cytometry
TNF 2 ng/mL TNF 2 ng/mL + anti-PR3 TNF 2 ng/mL + anti-MPO fMLP
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
CD11a mPR3low 121 ± 13 121 ± 8 119 ± 7 109 ± 3
mPR3high 106 ± 5 108 ± 17 104 ± 7 99 ± 5
CD11b mPR3low 237 ± 37 242 ± 25 228 ± 27 215 ± 95
mPR3high 244 ± 13 250 ± 9 247 ± 9 280 ± 29
CD11c mPR3low 208 ± 45 202 ± 36 194 ± 25 174 ± 13
mPR3high 186 ± 26 209 ± 56 202 ± 37 196 ± 20
CD18 mPR3low 219 ± 17 200 ± 14 207 ± 23 213 ± 50
mPR3high 223 ± 16 204 ± 5 213 ± 17 217 ± 34
CD16 mPR3low 92 ± 11 91 ± 12 88 ± 12 55 ± 6
mPR3high 86 ± 9 82 ± 10 82 ± 8 52 ± 2
CD32 mPR3low 79 ± 6 63 ± 2 62 ± 3 51 ± 12
mPR3high 80 ± 3 63 ± 2 65 ± 3 58 ± 5
CD35 mPR3low 172 ± 29 153 ± 43 176 ± 38 138 ± 43
mPR3high 165 ± 29 145 ± 31 175 ± 42 125 ± 28
The data represent membrane expression for the indicated molecules after stimulation with TNF-a, TNF-a + monoclonal anti-PR3, TNF-a + monoclonal anti-MPO,
and fMLP, respectively, compared to unstimulated neutrophils (mean percentage ± SEM).
molecules in the low and high mPR3 subsets of neu-
trophils.
Mobilization of azurophilic, specific, and secretory
granules in mPR3high and mPR3low neutrophils
CD11b is mobilized from specific granules und our
data have demonstrated no difference in the mobilization
of these granule types. We therefore investigated de-
granulation of azurophilic granules (CD63) and secretory
vesicles (CD35) to study if differences in mPR3 expres-
sion resulted from a more general difference in the abil-
ity to mobilize intracellular storages that contain PR3.
However, we found similar expression of CD35 in rest-
ing mPR3high and mPR3low neutrophils as well as after
stimulation (Fig. 8 and Table 1). CD63 increased only af-
ter the stimulation with fMLP, but not when cells were
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Fig. 7. The expression of the Fcc receptor IIA (CD32) and FccIIIb
(CD16) in mPR3high and mPR3low neutrophils was compared by dou-
ble staining and flow cytometry. Unstimulated isolated neutrophils were
stained with both anti-PR3 and anti-Fcc receptor mab. The data demon-
strate no difference in the expression of CD16 (A) or CD32 (B), with
respect to the mPR3 expression.
challenged with TNF-a, the mab to PR3, or the mab to
MPO (data not shown). However, no difference in CD63
expression with respect to mPR3 subset was observed.
These experiments do not support the contention that
mPR3high and mPR3low subsets result from differences
in the ability to mobilize granules or vesicles. Additional
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Fig. 8. The expression of the degranulation markers CD35 (CR1) and
CD63 in mPR3high and mPR3low neutrophils was compared by double
staining and flow cytometry. Unstimulated isolated neutrophils were
stained with both anti-PR3 and anti-CD63 or anti-CD35 mab. The data
demonstrate no difference in the expression of CD63 (A) or CD35 (B)
with respect to the mPR3 expression.
flow cytometry experiments were performed to assess the
membrane expression pattern of other serine proteinases
and MPO as another ANCA antigen. Our results indicate
that only PR3, but not elastase, cathepsin G, or MPO,
was characterized by a bimodal membrane distribution
(Fig. 9).
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Fig. 9. The expression of PR3 (A), MPO (B), elastase (C), and cathepsin G (D) was studied by flow cytometry. The gray line shows staining with
the appropriate isotype control, the shaded curve depicts staining with the specific antibody in unstimulated cells, and the bold line after treatment
with 2 ng/mL TNF-a. The data demonstrate that only membrane PR3 expression is bimodal.
Transmigration of separated neutrophils and
surface-staining for mPR3 after migration
Finally, we investigated potential consequences of
mPR3 expression in a more general setting—in the ab-
sence of ANCA. We tested the hypothesis that mPR3high
neutrophils would transmigrate faster through extra-
cellular matrix toward an interleukin (Il)-8 gradient.
Transwell plates were coated with fibronectin, an extra-
cellular matrix that is easily degraded by PR3. mPR3high
and mPR3low were separated and subjected to the upper
well. Cells that had migrated into the IL-8–containing
lower well were assayed. Under these conditions no
difference was observed (Fig. 10). To exclude that this
result was influenced by the mab to PR3 that was used
for cell sorting, and could still be bound to the neutrophil
surface, we repeated these experiments using a different
approach. Transmigration of unseparated neutrophils
toward an IL-8 chemotactic gradient was monitored. We
hypothesized that mPR3high neutrophils would migrate
faster through fibronectin, and therefore cells with the
higher mPR3 expression would arrive at first in the lower
well. Thus, we collected transmigrated cells at 30-minute
intervals up to 120 minutes, and performed surface stain-
ing for membrane PR3. There was no migration advan-
tage for mPR3high neutrophils at any of the indicated time
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Fig. 10. Neutrophil migration through fibronectin-coated transwells
toward an IL-8 gradient. (A) mPR3high and mPR3low were separated
from healthy donors by magnetic cell sorting and 1.5 × 106 cells were
applied to the upper chamber. Neutrophils that migrated into the lower
chamber were quantified by MPO assay after 30-minute time intervals
up to 120 minutes (mPR3high are shown as white bars, and mPR3low
as black bars). The data show no difference in the transmigration
through fibronectin-coated transwells between both subsets. (B) Unsep-
arated neutrophils (1.5 × 106) were stimulated to transmigrate through
fibronectin-coated transwells. Cells were harvested at the indicated time
points and stained for membrane PR3 expression. These data show no
migration advantage for mPR3high neutrophils at any of the indicated
time points.
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Fig. 10. Continued.
points (Fig. 10). These data suggest that mPR3 phenotype
is not the only determinant of neutrophil transmigration,
and that additional proteolytic enzymes are at work, com-
pensating for differences in mPR3 expression.
DISCUSSION
We explored the functional consequences of mPR3high
and mPR3low neutrophil phenotypes in the setting of
PR3-ANCA vasculitis. Our data are the first to show
that PR3-ANCA–induced generation of reactive oxy-
gen species and release of granule proteins are signifi-
cantly higher in the mPR3high neutrophil subset than in
the mPR3low subset. In addition, we found significant
stronger activation of the PI3-K/Akt pathway in PR3-
ANCA–stimulated mPR3high neutrophils. Moreover, the
mPR3high and mPR3low subsets differed neither in the
ability to mobilize primary, specific, and secretory gran-
ules, nor in the expression of other molecules with
putative implications in ANCA-induced neutrophil
activation.
In WG, PR3 is the major autoantigen recognized by
ANCA. This serine protease is stored intracellularly
in azurophilic, specific, and secretory granules of neu-
trophils [14–16, 28], but some PR3 can also be detected
on the cell surface of resting cells [17, 19]. mPR3 expres-
sion is bimodal and an mPR3high and mPR3low subset can
be distinguished [18, 19].
ANCA can activate TNF-a–primed neutrophils, and
activated neutrophils induce endothelial cell damage.
Whether or not the mPR3 phenotype is of functional
significance for the activation process is yet unknown;
however, the PR3 phenotype could be one of the reasons
for the clinical observation that WG patients with a larger
percentage of mPR3high neutrophils have higher relapse
rates during the disease [21]. We tested the hypothesis
that PR3-ANCA can more easily interact with mPR3high
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neutrophils resulting in increased cell activation. Our
data, obtained using physically separated mPR3high and
mPR3low subsets of a given donor, demonstrate that
PR3-ANCA indeed triggered a significantly stronger
respiratory burst activity and degranulation in mPR3high
neutrophils compared with the mPR3low counterparts
of the same individual. Neutrophil responses show high
donor variability. The advantage of our approach was to
exclude this donor variability that may have influenced
our results, had we merely compared different low
and high mPR3 expressing donors. “Reintroducing”
mPR3high cells into mPR3low samples of the same donor
increased the ability of PR3-ANCA to trigger a higher
degree of superoxide generation, demonstrating the
dose-dependency of this effect. Finally, differences in the
activation of the mPR3high cells and mPR3low subset oc-
curred only when PR3-ANCA were used for stimulation,
but not when other compounds, such as MPO-ANCA,
control immunoglobulins, PMA, or fMLP were
employed.
In search for mechanisms explaining our functional ob-
servations, we studied intracellular signaling events with
respect to the mPR3 expression. We and others demon-
strated recently that the PI3-K/Akt pathway is activated
by ANCA, but not by control immunoglobulins, and that
this pathway controls ANCA-induced respiratory burst
[4, 5]. In agreement with these observations, we found in
this study that activation of PI3-K/Akt was significantly
stronger in PR3-ANCA–treated mPR3high cells in com-
parison to their mPR3low counterparts from the same
individual. These data underscore the importance of the
antibody antigen interaction for ANCA-induced neu-
trophil activation. Our findings may, at least in part, ex-
plain the differences in the clinical course in WG patients
dependent on the mPR3 phenotype.
However, additional surface molecules were im-
plicated in ANCA-induced neutrophil activation,
including Fcc receptors and b2-integrins. Therefore,
we studied the expression of these molecules with
respect to the mPR3 phenotype. Both cross-linking of
ANCA target antigens on the surface of neutrophils
and engagement of Fcc receptors may play a role in the
activation process [4, 8–10, 29–31]. We observed that
expression of the Fcc receptors IIa and IIIb was similar
on mPR3high and mPR3low neutrophils. In addition to
Fcc-receptors, b2-integrins were implicated in ANCA-
mediated neutrophil activation. This class of integrins
consists of a common b chain (CD18) that is nonco-
valently linked to three unique but related a-chains
(CD11a, CD11b, CD11c). In fact, CD11b/CD18 were
up-regulated in granulocytes of patients with active WG
[32], and ANCA-positive sera stimulated up-regulation
of the same adhesion molecule in vitro [33]. Moreover,
using blocking antibodies to CD18, Reumaux et al
demonstrated that activation of the respiratory burst by
ANCA was dependent on engagement of b2-integrins
[10]. However, when we investigated membrane expres-
sion of CD11a, CD11b, CD11c, or CD18 with respect
to the mPR3high and mPR3low subset, we found no
differences. Low and high mPR3 expressing cells did
also not differ in their ability to adhere to extracellular
matrix proteins. These data indicate that differentially
expressed mPR3 is not accompanied by differences in the
expression of other surface molecules that are implicated
in ANCA-mediated neutrophil activation. This finding
holds true for constitutive expression, as well as for
up-regulated expression during activation, and provides
further support for the importance of ANCA-binding
to the target antigens in the activation process because
mPR3 expression was the only identifiable variable on
both neutrophil subsets. We investigated a total of 12
membrane molecules, and we excluded bimodal expres-
sion also of other serine proteinases, such as elastase
and cathepsin G and the second main ANCA target
antigen, MPO. However, we cannot exclude additional
yet unknown differences that may have influenced our
findings and may play a role in neutrophil activation by
ANCA.
We demonstrated recently that the intracellular con-
tent of PR3 was similar in mPR3high and mPR3low neu-
trophils [20]. Thus, conceivably low and high mPR3
expression may result from differences in the abil-
ity to mobilize intracellular granules. PR3 is found in
azurophilic, specific, and secretory granules [14–16]. We
used markers for all three of these granules and did
not find differences in the translocation of azurophilic
(CD63), specific (CD11a), or secretory (CD35) vesicles
when comparing both mPR3 subsets. Further studies are
needed to explore this issue. Potential explanations in-
clude modifications in the PR3 molecule itself resulting
in more or less effective membrane insertion or differ-
ences in PR3 receptor status. In fact, a PR3 receptor was
suggested in endothelial cells [34], but evidence for its
existence in neutrophils is still lacking.
Finally, we investigated potential consequences of the
mPR3 phenotype in a more general biological setting in
the absence of ANCA. We explored neutrophil migra-
tion through extracellular matrix toward a chemotactic
gradient and speculated that mPR3high neutrophils had
a migration advantage in that they would more easily
degrade matrix substance such as fibronectin. Cepinskas
et al demonstrated that membrane-bound elastase plays a
role in transmigration [35, 36]. MembranePR3 is a bioac-
tive enzyme and is, in contrast to soluble PR3, resistant
to physiologic proteinase inhibitors [22]. Using two dif-
ferent approaches, we did not find accelerated transmi-
gration of mPR3high neutrophils through a fibronectin
matrix.
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CONCLUSION
Our data demonstrate functional consequences of the
mPR3 expression phenotype in human neutrophils in the
presence of PR3-ANCA. This study may shed some light
in the clinical observation that a larger percentage of
mPR3high subset is associated with both the occurrence
and a higher relapse rate in WG patients.
Reprint requests to Ralph Kettritz, M.D., Division of Nephrology,
Franz Volhard Clinic, Wiltbergstrasse 50, 13122 Berlin, FRG.
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